A recent study has shown that RNF5 ameliorated nonalcoholic steatohepatitis (NASH) through ubiquitin-mediated degradation of 3-hydroxy-3-methylglutaryl CoA reductase degradation protein 1 [ref. 12]. Here, RNF5 is linked to metabolic dysfunction-associated steatohepatitis.